Inventor
STEIGERWALD ROBIN
DE26 patents
⚠️ This page may combine multiple inventors who share the name “STEIGERWALD ROBIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAVARIAN NORDIC AS
22 patentsUS9463238B2Oct 11, 2016
Recombinant poxvirus vector comprising tetanus toxin fragment C
BAVARIAN NORDIC AS3 citations73
US11225673B2Jan 18, 2022
Stable recombinant MVA vectors comprising modified RSV genes with reduced intramolecular recombinatorial activity
BAVARIAN NORDIC AS0 citations62
US10072274B2Sep 11, 2018
Vector comprising multiple homologous nucleotide sequences
BAVARIAN NORDIC AS1 citations62
US11571471B2Feb 7, 2023
Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine
BAVARIAN NORDIC AS0 citations61
US11103570B2Aug 31, 2021
Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (FMDV) vaccine
BAVARIAN NORDIC AS1 citations61
US11028130B2Jun 8, 2021
PR13.5 promoter for robust T-cell and antibody responses
BAVARIAN NORDIC AS0 citations61
US10946089B2Mar 16, 2021
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
BAVARIAN NORDIC AS0 citations61
US10881725B2Jan 5, 2021
Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccine
BAVARIAN NORDIC AS1 citations61
US11918639B2Mar 5, 2024
Methods and compositions for inducing protective immunity against filovirus infection
BAVARIAN NORDIC AS0 citations59
US11338030B2May 24, 2022
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens
BAVARIAN NORDIC AS0 citations59
US11173201B2Nov 16, 2021
Methods and compositions for inducing protective immunity against filovirus infection
BAVARIAN NORDIC AS0 citations59
US10561722B2Feb 18, 2020
Methods and compositions for enhancing immune responses
BAVARIAN NORDIC AS1 citations58
US9540660B2Jan 10, 2017
Vector comprising multiple homologous nucleotide sequences
BAVARIAN NORDIC AS0 citations51
US10532094B2Jan 14, 2020
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
BAVARIAN NORDIC AS0 citations50
US10124058B2Nov 13, 2018
Recombinant modified vaccinia virus Ankara (MVA) Respiratory Syncytial Virus (RSV) vaccine
BAVARIAN NORDIC AS0 citations50
US10111946B2Oct 30, 2018
Poxviral vectors for low antibody response after a first priming immunization
BAVARIAN NORDIC AS0 citations50
US9828414B2Nov 28, 2017
Pr13.5 promoter for robust T-cell and antibody responses
BAVARIAN NORDIC AS1 citations50
US9717787B2Aug 1, 2017
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
BAVARIAN NORDIC AS0 citations50
US9480738B2Nov 1, 2016
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
BAVARIAN NORDIC AS0 citations50
US10561721B2Feb 18, 2020
Methods and compositions for inducing protective immunity against filovirus infection
BAVARIAN NORDIC AS0 citations49
US10653766B2May 19, 2020
Use of oil and water emulsions for increasing B cell responses with modified Vaccinia Ankara virus
BAVARIAN NORDIC AS0 citations48
US10576141B2Mar 3, 2020
Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of use
BAVARIAN NORDIC AS0 citations46